axonics.com - AXNX Company Value to Revenue Ratio

Public company logo of Axonics (AXNX)

The EV/Sales valuation on the GURU.Markets chart demonstrates the enterprise value to sales ratio, where the current value is 21206.90. Axonics, Inc. (AXNX) has created a unique neuromodulation environment, maintaining market dominance through surgeon certification. The company generates revenue from the sale of implants for the therapy of pelvic dysfunction. Patent protection and a deal with a major medtech behemoth make this niche virtually inaccessible to new players.

AXNX Axonics, Inc.: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

AXNX (Axonics Modulation Technologies): analytical breakdowns and indicator data

Fundamental valuation:Axonics, Inc. AXNX
Mass-produced product of Axonics Inc.

This indicator measures the total business value minus net debt relative to sales volume, revealing a critical gap between market expectations and actual cash flow generation. By analyzing the Enterprise Value to revenue ratio, an investor can assess the justification for the capitalization premium, which for Axonics, Inc. (AXNX) is supported by strong pricing power and the uniqueness of its rechargeable stimulators.

Competitor analysis for Axonics, Inc.

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|PODD (Insulet Inc.) - EV/Sales Multiple|Company Value to Revenue Zimmer Biomet Corp (ZBH)|EV/Sales Multiple COO|Company Value to Revenue Align Technology, Inc. ALGN|EV/Sales Multiple GMED (globusmedical.com)|EV/Sales Multiple TransMedics Group, Inc. TMDX|ATEC - Enterprise Value-to-Revenue Ratio|AORT: Enterprise Value-to-Revenue Ratio|ENOV (Enovis Corporation) - Company Value to Revenue|Integra LifeSciences - Business Value to Revenue|ESTA (Establishment Labs Inc) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Beta Bionics, Inc. BBNX|Enterprise Value-to-Revenue Ratio IRADIMED Corp (IRMD)|Embecta Corp. (EMBC) - Enterprise Value-to-Sales Ratio|Tandem Corp - Company Value to Revenue|EV/Sales Multiple AxoGen, Inc. AXGN|SI-BONE Inc - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Orthofix Medical OFIX|Bioventus Global (BVS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume KIDS (OrthoPediatrics Inc.)|Enterprise Value-to-Revenue Ratio treace.com|Company Value to Revenue Strata Critical Medical Inc (SRTA)|EV/Sales Multiple CARL|RXST - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio clearpointneuro.com CLPT|STXS: Company Value to Revenue Ratio|STIM: Company Value to Revenue|sightsciences.com - Enterprise Value-to-Revenue Coefficient|Orchestra BioMed Inc. (OBIO) - Enterprise Value-to-Revenue Ratio|Anika (ANIK) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio InspireMD, Inc.|zhjmedical.com (ZJYL) - Total Company Value-to-Revenue Ratio|Company Value to Revenue VANI (Vivani Medical)|EV/Sales Multiple Xtant Medical Holdings, Inc. (XTNT)|Enterprise Value-to-Revenue Ratio NeuroOne Medical Technologies Corporation NMTC|EV/Sales Multiple Modular Medical MODD|MYO: Company Value to Revenue|Enterprise Value-to-Revenue Multiple Envoy Medical, Inc.|VVOS (Vivos Therapeutics) - Company Value to Revenue|Company Value to Revenue Ratio NVNO|Company Value to Revenue SINT|Company Value to Revenue Tenon Medical (TNON)|Enterprise Value-to-Revenue Ratio ReWalk Robotics Ltd (LFWD)|Total Company Value-to-Revenue Ratio Autonomix|EV/Sales Multiple IVF (invobioscience.com)|bonebiologics.com - Enterprise Value-to-Revenue Ratio|BIOL - Enterprise Value-to-Revenue Ratio|Dynatronics (DYNT) - Company Value to Revenue|Paragon 28, Inc. (FNA) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio